![]() |
|||||||
PC-SPES RECALLED, LAWSUITS FILED, INDICTMENTS ISSUED
The first tangible indication of real trouble began February 7, 2002 with a warning from the California Department of Health. Shortly thereafter, BotanicLAB, the maker of PC-SPES, voluntarily recalled the product, and on June 1, 2002, the company ceased operation. On February 14, 2003, California Assemblyman Mervyn Dymally introduced into the state legislature AB-421, a bill to revive PC-SPES. However, on June 2, 2003, a grand jury in Orange County, CA issued criminal indictments against the principles of the company (Sophie and John Chen and Alan Wang). Arraignment is scheduled for June 23 California AB-421 has been put on hold, and the estimated 10,000 American men who had been using PC-SPES to control their prostate cancer are now looking for other remedies. And the scientists who had been keenly interested in this novel compound are now in a quandry. The outcome of this legal case will be watched with intense interest
by both the lay and scientific communities.
|
|||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Howard Soule, Ph.D. CapCURE Foundation "Welcome" |
Sophie Chen, Ph.D. New York Medical College "PC-SPES, Historical and scientific insights" |
![]() |
||||
![]() |
|||||||
![]() |
Leonard S. Marks, M.D. UCLA School of Medicine and USRF "Introductions, background, mission statement" |
Mark Blumenthal American Botanical Council "Herbal therapy of prostate cancer" |
![]() |
||||
![]() |
|||||||
![]() |
Arie Belldegrun, M.D. UCLA School of Medicine "Medical therapy of advanced prostate cancer" |
Robert DiPaola, M.D. NJSMD-Robert Wood Johnson School of Medicine "PC-SPES, Clinical and biological activity" |
![]() |
||||
![]() |
|||||||
![]() |
Franklin Lowe, M.D. Columbia University School of Medicine "Alternative therapy of prostate cancer" |
Peter Nelson, M.D. University of Washington School of Medicine "PC-SPES, Clinically relevant molecular pathways" |
![]() |
||||
![]() |
|||||||
![]() |
Floyd Leaders, Jr., Ph.D. Botanical Enterprises, Inc. (BEI-Botanicals) "Herbal medicine and the FDA" |
Leonard S. Marks, M.D. UCLA School of Medicine and USRF "PC-SPES, overview of clinical trials" |
![]() |
||||
|